Target intelligence / Profile preview

Multiple cysteine-rich proteins

Molecular classification
Other, For certain subgroups: "Enzyme", "Receptor", "Transcription factor", "Ion channel", etc. (depending on the specific protein/family)
01

Overview

"Multiple cysteine-rich proteins" is a **generic descriptor** rather than a single molecular entity or therapeutic target. Cysteine-rich proteins (CRPs) are a broad and structurally diverse group of small proteins characterized by the presence of many cysteine residues, which can form disulfide bonds for structural stability or coordinate metal ions, allowing them to serve varied roles in biological systems[1]. These proteins are found in bacteria, plants, animals, and humans. Key families include plant CRPs involved in defense and reproduction, cysteine-rich secretory proteins (CRISPs) important in mammalian reproduction and venom activity, and cysteine-rich intestinal proteins (CRIPs) implicated in cancer and cardiovascular biology[3][5][6]. Due to this heterogeneity, "multiple cysteine-rich proteins" does not refer to a single gene, protein, or drug target, making this designation **non-specific, non-canonical, and not a recognized therapeutic target**. --- The term as provided is **incorrect** as a drug or therapeutic target, as it refers to a vast and heterogeneous superfamily of proteins with very different functions across organisms. To retrieve structured and target-specific information, a precise, individual protein or well-defined family name is required (e.g., "Cysteine-rich secretory protein 1" or "Cysteine-rich intestinal protein 2")[1][3][5][6].

Other names
Cysteine-rich proteinCRPCysteine-rich peptideDisulfide-rich peptideCysteine-rich secretory protein (CRISP, for a subgroup)Secreted cysteine-rich repeat proteins (SCREP, for a structurally-defined subclass)
02

Mechanism of action

Varies by protein/family: - Structural stabilization by disulfide bond formation or metal chelation - Signal transduction via interaction with receptors or transcription factors - Enzyme inhibition (as protease, amylase inhibitors) - Receptor blocking (e.g., venom proteins affecting ion channels)

03

Biological functions

Protein structural stabilization (via disulfide bond formation or metal ion chelation)Signal transduction (in some families, notably plant CRPs and certain mammalian CRIPs/CRISPs)Plant defense and immunityCell-cell signaling in plant reproductionEnzyme inhibition (e.g., protease inhibitors, amylase inhibitors)Toxin activity (in the case of venom peptides)Cell deathCell growth and differentiation
04

Disease associations

Cancer (e.g., CRIP1, CRIP2 in tumor progression)Cardiovascular disease risk (e.g., CRIP family as potential biomarkers)Infection (e.g., plant and animal antimicrobial peptides, toxins)Neurodegeneration (some snake toxin CRPs affect neuronal signaling)Other (very diverse, highly context-dependent on subclass/family)
05

Safety considerations

None generic; specific toxins in this class (e.g., venom cysteine-rich peptides) can be highly toxic to humans or animalsImmunogenic or allergenic potential for some plant CRPs
06

Interacting drugs

None broadly applicable; for subgroups like CRIP2 or other specific members, research into inhibitors is ongoing but no approved drugs exist
07

Biomarkers

Some CRIPs (notably CRIP1, CRIP2) have been proposed as biomarkers for cancer and cardiovascular disease

Beyond the preview

Go deeper on Multiple cysteine-rich proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cysteine-rich proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call